|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S2
|
$50,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S3
|
$5,694,947
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$1,227,708
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
|
ZIA BC 010015
|
$328,101
|
Wang, Ji Ming
|
CCR (NCI)
|
|
TAS::75 0849::TAS INCREMENTAL FUNDING
|
N01CO800001-038
|
$221,493,424
|
HEIMBROOK, DAVID
|
SAIC-FREDERICK, INC.
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
ZIA BC 010806
|
$322,491
|
Khan, Javed
|
CCR (NCI)
|
|
Sulfatide-reactive type II NKT cells: repertoire and function
|
5R01CA100660-07
|
$349,565
|
Kumar, Vipin
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
|
Statistical Inference on Chemotherapy Effects from Flow Cytometry Data
|
5R01CA134839-04
|
$227,432
|
Hyrien, Ollivier
|
UNIVERSITY OF ROCHESTER
|
|
South Texas Pediatric Minority Based CCOP
|
3U10CA052771-21S1
|
$50,000
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
South Texas Pediatric Minority Based CCOP
|
5U10CA052771-21
|
$321,790
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$489,703
|
Daar, Ira
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$388,254
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$388,254
|
Tessarollo, Lino
|
CCR (NCI)
|
|
RNA interference approach to dissect roles of notochord regulators
|
ZIA BC 011121
|
$80,056
|
Mackem, Susan
|
CCR (NCI)
|
|
Riluzole Prodrugs for Melanoma and ALS
|
1R43CA156781-01
|
$336,255
|
Reitz, Allen
|
FOX CHASE CHEMICAL DIVERSITY CENTER, INC
|
|
Research Training in Neuro-Oncology
|
5T32CA009574-24
|
$238,542
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
|
5R01CA122617-06
|
$258,308
|
MANNING, BRENDAN
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
Regulation of the mTOR Pathway By Nutrients
|
5R01CA103866-08
|
$378,696
|
SABATINI, DAVID
|
WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$469,166
|
Thiele, Carol
|
CCR (NCI)
|
|
Protein Structure, Stability, and Amyloid Formation
|
ZIA BC 010440
|
$475,236
|
Nussinov, Ruth
|
CCR (NCI)
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$420,341
|
Kleiner, David
|
CCR (NCI)
|
|
Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with Hi
|
ZIA BC 010590
|
$46,106
|
Warren, Katherine
|
CCR (NCI)
|
|
Pediatric Clinical Oncology Research Training Program
|
3K12CA090433-10S1
|
$134,042
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Clinical Oncology Research Training Program
|
5K12CA090433-10
|
$475,607
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Cancer, Family Conflict and Child Adjustment
|
5R01CA134794-02
|
$341,099
|
KATZ, LYNN
|
UNIVERSITY OF WASHINGTON
|
|
Pediatric Brain Tumor Consortium (PBTC)
|
5U01CA081457-13
|
$2,220,171
|
BOYETT, JAMES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIA BC 010789
|
$469,166
|
Thiele, Carol
|
CCR (NCI)
|
|
North Central Cancer Treatment Group
|
3U10CA025224-32S1
|
$1,347,651
|
BUCKNER, JAN
|
MAYO CLINIC
|
|
North Central Cancer Treatment Group
|
5U10CA025224-32
|
$5,018,658
|
BUCKNER, JAN
|
MAYO CLINIC
|
|
Nanomaterials for Cancer Diagnostics and Therapeutics
|
3U54CA151880-02S1
|
$57,724
|
MIRKIN, CHAD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Nanomaterials for Cancer Diagnostics and Therapeutics
|
5U54CA151880-02
|
$2,329,637
|
MIRKIN, CHAD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,104,407
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma
|
ZIA BC 010540
|
$184,241
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Micro RNA Profiling in Pediatric Cancers
|
ZIA BC 011001
|
$107,497
|
Khan, Javed
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$489,703
|
Daar, Ira
|
CCR (NCI)
|
|
Mechanisms of ATM activation
|
5R01CA132813-03
|
$242,941
|
PAULL, TANYA
|
UNIVERSITY OF TEXAS AUSTIN
|
|
Iowa Womens Health Study Drinking Water Nitrate Analysis
|
ZIA CP010125-10347
|
$32,379
|
Ward, Mary
|
DCEG (NCI)
|
|
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
|
ZIA SC 004002
|
$1,295,164
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$881,476
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIA BC 010539
|
$644,844
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
ZIA SC 010366
|
$214,994
|
Khan, Javed
|
CCR (NCI)
|
|
Huntington Interacting Protein-1(HIP1) and the Promotion of Neoplasia
|
5R01CA098730-08
|
$258,083
|
ROSS, THEODORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$548,663
|
Gottesman, Michael
|
CCR (NCI)
|
|
FEN-1 and PCNA Complexes and Human Genome Stability
|
5R01CA081967-12
|
$340,683
|
TAINER, JOHN
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,420,622
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other Ge
|
ZIA BC 010801
|
$976,696
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Development of Mouse Astrocytoma Model for Preclinical Testing
|
ZIA BC 010541
|
$92,121
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Determining the Fate of Transmembrane Proteins
|
ZIA BC 009392
|
$733,412
|
Weissman, Allan
|
CCR (NCI)
|
|
Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes
|
ZIA BC 010734
|
$48,425
|
Hornyak, Thomas
|
CCR (NCI)
|
|
Consequences of receptor cross talk on inflammation and algesia
|
ZIA BC 010708
|
$56,648
|
Oppenheim, Joost
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|